Advertisement
News
Subscribe to MDT Magazine News

Federal Register: Reprocessing of Reusable Medical Devices; Public Workshop

May 2, 2011 4:30 am | by U.S. Food & Drug Administration | Comments

The Food and Drug Administration (FDA) is announcing a public workshop entitled: "Reprocessing of Reusable Medical Devices Workshop.' The purpose of the workshop is to discuss factors affecting the reprocessing of reusable medical devices

TOPICS:

Federal Register: Draft Guidance for Industry and FDA Staff; Availability: Processing/Reprocessing Medical Devices in Health Care Settings; Validation Methods and Labeling

May 2, 2011 4:30 am | by U.S. Food & Drug Administration | Comments

The Food and Drug Administration (FDA) is announcing the availability of the draft guidance document entitled "Draft Guidance for Industry and FDA Staff: Processing/Reprocessing Medical Devices in Health Care Settings: Validation Methods and Labeling."

TOPICS:

Humana posts 22 percent 1Q earnings gain

May 2, 2011 3:45 am | by The Associated Press | Comments

Humana Inc. reports that first-quarter profit rose 22 percent as the health insurer posted enrollment gains in its Medicare Advantage and stand-alone Medicare prescription drug plans.The company posted pretax income gains in its employer group and its health and well-being services...

Advertisement

IRIDEX Granted U.S. Patent for Stepped Angled Laser Handpieces Used in Eye Surgery

May 2, 2011 3:37 am | by Bio-Medicine.Org | Comments

MOUNTAIN VIEW, Calif., May 2, 2011 /- IRIDEX Corporation (Nasdaq: IRIX ) today announced that the U.S. Patent and Trademark Office had issued to IRIDEX a patent applying to a group of specially designed laser handpieces used in invasive ophthalmic surgical procedures. The patent, No....

TOPICS:

Henry Schein to Present at Deutsche Bank 36th Annual Health Care Conference

May 2, 2011 3:36 am | by Bio-Medicine.Org | Comments

MELVILLE, N.Y., May 2, 2011 /- Henry Schein, Inc., (NASDAQ: HSIC ), the largest provider of health care products and services to office-based practitioners, announced today that Stanley M. Bergman, Chairman and Chief Executive Officer of Henry Schein, and Steven Paladino, the Company's...

TOPICS:

Abaxis Appoints Vernon Altman to Board of Directors

May 2, 2011 3:36 am | by Bio-Medicine.Org | Comments

UNION CITY, Calif., May 2, 2011 /- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, today announced Vernon Altman has been appointed to the Company's Board of Directors, effective immediately. The addition of Mr. Altman brings...

TOPICS:

BioBehavioral Diagnostics takes in $300,000

May 2, 2011 3:34 am | by Mass High Tech: The Journal of New England Technology | Comments

BioBehavioral Diagnostics Co., which makes a medical device for attention deficit hyperactivity disorder (ADHD), has raised $300,000 in a sale of $500,000 in securities.

TOPICS:

Advice on Changing Practice Leadership

May 2, 2011 3:34 am | by Diagnostic Imaging | Comments

Our practice recently changed its leadership. That's a challenge for any business, but radiology has some unique problems.

TOPICS:
Advertisement

Case of the Week: Metastatic Melanoma

May 2, 2011 3:34 am | by Diagnostic Imaging | Comments

Findings of a gallbladder nondependent mass point to an unfortunate diagnosis

TOPICS:

Prometheus Obtains Exclusive US Commercialization Rights for RENCAREX®

May 2, 2011 3:34 am | by Bio-Medicine.Org | Comments

SAN DIEGO, May 2, 2011 /- Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced that it has signed an exclusive agreement with WILEX AG for commercialization rights in the United States for RENCAREX® (girentuximab).  RENCAREX® is a...

TOPICS:

Vertical Health Solutions to Begin Doing Business as OnPoint Medical Diagnostics and Announces Completion of Symbol Change

May 2, 2011 3:34 am | by Bio-Medicine.Org | Comments

MINNEAPOLIS, May 2, 2011 /- Vertical Health Solutions, Inc. (OTCQB: VHSLD) announced that it will begin doing business as OnPoint Medical Diagnostics and that the Financial Industry Regulatory Authority has approved a change in its ticker symbol from "VHSLD" to "ONMDD".  The stock...

TOPICS:

Grifols and Talecris Biotherapeutics Announce the Signing of a Consent Agreement With FTC Staff

May 2, 2011 1:34 am | by Bio-Medicine.Org | Comments

BARCELONA, Spain, May 2, 2011 /- Grifols, S.A. ("Grifols") and Talecris Biotherapeutics Holdings Corporation ("Talecris"), announced today that they have signed a "Consent Agreement" with the Staff of the Bureau of Competition of the US Federal Trade Commission (FTC) by means of which the...

TOPICS:

Reportlinker Adds Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies

May 2, 2011 1:33 am | by Bio-Medicine.Org | Comments

NEW YORK, May 2, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Drug Delivery in Central Nervous System Diseases - technologies,markets and companies...

TOPICS:

PET-CT exams help identify cognitive reserve in early-onset Alzheimer's disease

May 1, 2011 10:32 pm | by EurekAlert | Comments

(American Roentgen Ray Society) A recent study revealed that the "cognitive reserve" in early-onset Alzheimer's disease (AD) and PET-CT examinations can be used to effectively to identify early-onset AD patients.

TOPICS:

Advanced CT with 3-D scanning improve detection of drug trafficking and other contraband smuggling

May 1, 2011 9:37 pm | by EurekAlert | Comments

(American Roentgen Ray Society) With the high prevalence of drug abuse and trafficking in major cities throughout the world, one new study shows how advanced CT with 3-D scanning can help radiologists better identify ingested or hidden contraband items more effectively.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading